학술논문
The pan-PPAR agonist lanifibranor reduces development of lung fibrosis and attenuates cardiorespiratory manifestations in a transgenic mouse model of systemic sclerosis
Document Type
Article
Author
Source
In: Arthritis Research and Therapy . (Arthritis Research and Therapy, December 2021, 23(1))
Subject
Language
English
ISSN
14786362
14786354
14786354